Macroeconomic conditions and opioid abuse

Journal of Health Economics

Volumn 56, Issue , 2017, Pages 222-233

  Hollingsworth, Alex ^a   Ruhm, Christopher J ^b,c   Simon, Kosali ^a,c  

^a INDIANA UNIVERSITY   (United States)

^b UNIVERSITY OF VIRGINIA   (United States)

^c NATIONAL BUREAU OF ECONOMIC RESEARCH   (United States)

Author keywords

Macroeconomic conditions; Opioids; Unemployment

Indexed keywords

OPIATE;

DRUG USER; ECONOMIC CONDITIONS; MACROECONOMICS; MORTALITY; UNEMPLOYMENT;

ARTICLE; BLACK PERSON; CAUCASIAN; DEATH; DRUG OVERDOSE; EMERGENCY WARD; HISPANIC; HUMAN; MACROECONOMIC CONDITION; MORTALITY RATE; OPIATE ADDICTION; SOCIOECONOMICS; UNEMPLOYMENT; UNITED STATES; ADULT; ECONOMIC RECESSION; ECONOMICS; EPIDEMIOLOGY; FACTUAL DATABASE; FEMALE; MALE; MIDDLE AGED; MORTALITY; PSYCHOLOGY;

ADULT; DATABASES, FACTUAL; ECONOMIC RECESSION; FEMALE; HUMANS; MALE; MIDDLE AGED; OPIOID-RELATED DISORDERS; UNEMPLOYMENT; UNITED STATES;

EID: 85033380033     PISSN: 01676296     EISSN: 18791646     Source Type: Journal    
DOI: 10.1016/j.jhealeco.2017.07.009     Document Type: Article

References (66)

1. Ariizumi, H., Schirle, T., Are recessions really good for your health? Evidence from Canada. Soc. Sci. Med. 74:8 (2012), 1224–1231.
2. Arkes, J., Does the economy affect teenage substance use?. Health Econ. 16:1 (2007), 19–36.
3. Autor, D.H., Dorn, D., Hanson, G.H., The China syndrome: local labor market effects of import competition in the United States. Am. Econ. Rev. 103:6 (2013), 2121–2168.
4. Bair, M.J., Robinson, R.L., Katon, W., Kroenke, K., Depression and pain comorbidity. Arch. Int. Med., 163(20), 2003, 2433.
5. Bodkin, J.A., Zornberg, G., Lukas, S., Buprenorphine treatment of refractory depression. J. Clin. Psychopharmacol. 15 (1995), 49–57.
6. Braden, J.B., Sullivan, M.D., Ray, G.T., Saunders, K., Merrill, J., Silverberg, M.J., Rutter, C.M., Weisner, C., Banta-Green, C., Campbell, C., Von Korff, M., Trends in long-term opioid therapy for noncancer pain among persons with a history of depression. Gen. Hosp. Psychiatry 31:6 (2009), 564–570.
7. Buchmueller, T.C., Carey, C., The Effect of Prescription Drug Monitoring Programs on Opioid Utilization in Medicare. NBER Working Paper Series No. 23148. 2017.
8. Buchmueller, T.C., Grignon, M., Jusot, F., Unemployment and Mortality in France, 1982–2002. Technical Report 07-04., 2007, McMaster University.
9. Carpenter, C., McClellan, C., Rees, D., Economic Conditions, Illicit Drug Use, and Substance Use Disorders in the United States. NBER Working Paper Series No. 22051. 2016, 1–30.
10. Case, A., Deaton, A., Rising morbidity and mortality in midlife among white non-Hispanic Americans in the 21st century. Proc. Natl. Acad. Sci. U. S. A. 112:49 (2015), 15078–15083.
11. Cawley, J., Moriya, A.S., Simon, K., The impact of the macroeconomy on health insurance coverage: evidence from the great recession. Health Econ. 24 (2015), 206–223.
12. Centers for Disease Control and Prevention, Prescription Drug Overdose Data & Statistics: Guide to ICD-9-CM and ICD-10 Codes Related to Poisoning and Pain. 2013 Atlanta, GA. Retrieved from https://www.cdc.gov/drugoverdose/pdf/pdo_guide_to_icd-9-cm_and_icd-10_codes-a.pdf.
13. Centers for Disease Control and Prevention, Wonder, Multiple Cause of Death. 2016, 1999–2014.
14. Centers for Disease Control and Prevention, National Center for Health Statistics, Instructions for Completing the Cause-of-Death Section of the Death Certificate. 2017.
15. Charles, K.K., DeCicca, P., Local labor market fluctuations and health: is there a connection and for whom?. J. Health Econ. 27:6 (2008), 1532–1550.
16. Colman, G., Dave, D., Exercise, physical activity, and exertion over the business cycle. Soc. Sci. Med. 93 (2013), 11–20.
17. Crane, E.H., Emergency Department Visits Involving Narcotic Pain Relievers, Technical Report. Substance Abuse and Mental Health Services Administration., 2015, Center for Behavioral Health Statistics and Quality, Rockville, MD.
18. Dávalos, M.E., Fang, H., French, M.T., Easing the pain of an economic downturn: macroeconomic conditions and excessive alcohol consumption. Health Econ. 21:11 (2012), 1318–1335.
19. Dee, T.S., Alcohol abuse and economic conditions: evidence from repeated cross-sections of individual-level data. Health Econ. 10:3 (2001), 257–270.
20. Dobkin, C., Puller, S.L., The effects of government transfers on monthly cycles in drug abuse, hospitalization, and mortality. J. Public Econ. 91:11–12 (2007), 2137–2157.
21. Dowell, D., Zhang, K., Noonan, R.K., Hockenberry, J.M., Mandatory provider review and pain clinic laws reduce the amounts of opioids prescribed and over-dose death rates. Health Aff. 35:10 (2016), 1876–1883.
22. Durkheim, E., 2005. Suicide: A Study in Sociology. (J. A. Spaulding & G. Simpson, Trans.). Taylor & Francis Group, Paris.
23. Freeman, D.G., A note on ‘economic conditions and alcohol problems’. J. Health Econ. 18:5 (1999), 661–670.
24. Frijters, P., Johnston, D.W., Lordan, G., Shields, M.A., Exploring the relationship between macroeconomic conditions and problem drinking as captured by Google searches in the US. Soc. Sci. Med. 84 (2013), 61–68.
25. Ganong, P., Liebman, J., The Decline, Rebound, and Further Rise in SNAP Enrollment: Disentangling Business Cycle Fluctuations and Policy Changes. NBER Working Paper Series No. 19363. 2013.
26. Gerdtham, U.-G., Ruhm, C.J., Deaths rise in good economic times: evidence from the OECD. Econ. Hum. Biol. 4:3 (2006), 298–316.
27. Gonzalez, F., Quast, T., Macroeconomic changes and mortality in Mexico. Empir. Econ. 40:2 (2011), 305–319.
28. Gruber, J., Frakes, M., Does falling smoking lead to rising obesity?. J. Health Econ. 25:2 (2006), 183–197.
29. Hamermesh, D.S., Soss, N.M., An economic theory of suicide. J. Polit. Econ. 82:1 (1974), 83–98.
30. Hardesty, C., White House Summit on the Opioid Epidemic. 2014.
31. Johansson, E., Böckerman, P., Prättälä, R., Uutela, A., Alcohol-related mortality, drinking behavior, and business cycles: are slumps really dry seasons?. Eur. J. Health Econ. 7:3 (2006), 212–217.
32. Jones, C.M., Logan, J., Gladden, R.M., Bohm, M.K., Vital Signs: Demographic and Substance Use Trends Among Heroin Users, United States, 2002–2013. Technical Report 26., 2015.
33. Koran, L.M., Aboujaoude, E., Bullock, K.D., Franz, B., Gamel, N., Elliott, M., Double-blind treatment with oral morphine in treatment-resistant obsessive compulsive disorder. J. Clin. Psychiatry 66:3 (2005), 353–359.
34. Lam, J.-P., Piérard, E., The time-varying relationship between mortality and business cycles in the USA. Health Econ., 19, 2015, 11.
35. Lin, S.-J., Economic fluctuations and health outcome a panel analysis of Asia Pacific countries. Appl. Econ. 41:4 (2009), 519–530.
36. Lindo, J.M., Aggregation and the estimated effects of economic conditions on health. J. Health Econ. 40 (2015), 83–96.
37. Maclean, J.C., Cantor, J.H., Pacula, R.L., Economic Downturns and Substance Abuse Treatment: Evidence from Admissions Data. NBER Working Paper Series No. 19115. 2015.
38. Martin Bassols, N., Vall Castelló, J., Effects of the great recession on drugs consumption in Spain. Econ. Hum. Biol. 22 (2016), 103–116.
39. McInerney, M., Mellor, J.M., Recessions and seniors’ health, health behaviors, and healthcare use: analysis of the Medicare Current Beneficiary Survey. J. Health Econ. 31:5 (2012), 744–751.
40. Modrek, S., Hamad, R., Cullen, M.R., Psychological well-being during the great recession: changes in mental health care utilization in an occupational cohort. Am. J. Public Health 105:2 (2015), 304–310.
41. Neumayer, E., Recessions lower (some) mortality rates: evidence from Germany. Soc. Sci. Med. 58:6 (2004), 1037–1047.
42. Ogburn, W.F., Thomas, D.S., The influence of the business cycle on certain social conditions. J. Am. Stat. Assoc., 18(139), 1922, 324.
43. Pierce, J. Jr., Denison, A.V., Place-of-residence errors on death certificates for two contiguous U.S. counties. Popul. Health Metr., 4(1), 2006, 6.
44. Pierce, J.R., Schott, P.K., Trade Liberalization and Mortality: Evidence from U.S. Counties. NBER Working Paper Series No. 22849. 2016, 66.
45. Rees, D., Sabia, J., Argys, L., Latshaw, J., Dave, D., With a Little Help from My Friends: The Effects of Naloxone Access and Good Samaritan Laws on Opioid-Related Deaths. NBER Working Paper Series No. 23171. 2017.
46. Riddell, C., Riddell, R., Welfare checks, drug consumption, and health: evidence from Vancouver injection drug users. J. Hum. Resour. XLI:1 (2006), 138–161.
47. Rudd, R.A., Aleshire, N., Zibbell, J.E., Gladden, R.M., Increases in drug and opioid overdose deaths – United States 2000–2014. Morb. Mortal. Wkly. Rep. 64:50–51 (2016), 1378–1382.
48. Ruhm, C.J., Are recessions good for your health?. Q. J. Econ. 115:2 (2000), 617–650.
49. Ruhm, C.J., Good times make you sick. J. Health Econ. 22:4 (2003), 637–658.
50. Ruhm, C.J., Healthy living in hard times. J. Health Econ. 24:2 (2005), 341–363.
51. Ruhm, C.J., Understanding the relationship between macroeconomic conditions and health. The Elgar Companion to Health Economics, 2nd ed., 2012, Edward Elgar Publishing, 5–14.
52. Ruhm, C.J., Recessions, healthy no more?. J. Health Econ., 42, 2015, 17.
53. Ruhm, C.J., Drug involvement in fatal overdoses. SSM Popul. Health 3:December (2017), 219–226.
54. Ruhm, C.J., Black, W.E., Does drinking really decrease in bad times?. J. Health Econ. 21:4 (2002), 659–678.
55. Schwartz, B.G., Pezzullo, J.C., McDonald, S.A., Poole, W.K., Kloner, R.A., How the 2008 stock market crash and seasons affect total and cardiac deaths in Los Angeles County. Am. J. Cardiol. 109:10 (2012), 1445–1448.
56. Shierholz, H., Labor Force Participation: Cyclical Versus Structural Changes Since the Start of the Great Recession. Technical Report 333., 2012, Economic Policy Institute.
57. Stevens, A.H., Miller, D.L., Page, M.E., Filipski, M., The best of times, the worst of times: understanding pro-cyclical mortality. Am. Econ. J. Econ. Policy 7:4 (2015), 279–311.
58. Sullivan, M.D., Edlund, M.J., Zhang, L., Unützer, J., Wells, K.B., Association between mental health disorders, problem drug use, and regular prescription opioid use. Arch. Int. Med., 166(19), 2006, 2087.
59. Tadros, A., Layman, S.M., Davis, S.M., Davidov, D.M., Cimino, S., Emergency visits for prescription opioid poisonings. J. Emerg. Med. 49:December (6) (2015), 871–877, 10.1016/j.jemermed.2015.06.035 [Epub 2015 Sep 26].
60. Tapia Granados, J.A., Recessions and mortality in Spain, 1980–1997. Eur. J. Popul. 21:4 (2005), 393–422.
61. Tekin, E., McClellan, C., Minyard, K.J., Health and Health Behaviors During the Worst of Times. NBER Working Paper Series No. 19234. 2013.
62. Volkow, N.D., Frieden, T.R., Hyde, P.S., Cha, S.S., Medication-assisted therapies — tackling the opioid-overdose epidemic. N. Engl. J. Med. 370:22 (2014), 2063–2066.
63. Warner, M., Chen, L.H., Makuc, D.M., Anderson, R.N., Miniño, A.M., Drug Poisoning Deaths in the United States, 1980–2008. Technical Report 81., 2011, U.S. Department of Health and Human Services. Centers for Disease Control and Prevention. National Center for Health Statistics.
64. World Health Organization. 2014. International Classification of Diseases (ICD). Retrieved March 6, 2017, from http://www.who.int/classifications/icd/en/.
65. Wu, L.-T., Woody, G.E., Yang, C., Pan, J.-J., Blazer, D.G., Racial/ethnic variations in substance-related disorders among adolescents in the United States. Arch. Gen. Psychiatry 68:11 (2011), 1176–1185, 10.1001/archgenpsychiatry.2011.120.
66. Xu, X., The business cycle and health behaviors. Soc. Sci. Med. 77:1 (2013), 126–136.